Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeWages, Salaries and Other
Others
EBIATLong-Term Debt IssuancesWages, Salaries and Other
Ratios

Nu-Med Plus (NUMD) Shares Outstanding (2016 - 2025)

Nu-Med Plus' Shares Outstanding history spans 11 years, with the latest figure at $79.3 million for Q4 2021.

  • On a quarterly basis, Shares Outstanding rose 55.5% to $79.3 million in Q4 2021 year-over-year; TTM through Dec 2021 was $79.3 million, a 55.5% increase, with the full-year FY2021 number at $79.3 million, up 55.5% from a year prior.
  • Shares Outstanding hit $79.3 million in Q4 2021 for Nu-Med Plus, roughly flat from $79.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for NUMD hit a ceiling of $79.3 million in Q1 2021 and a floor of $37.2 million in Q1 2017.
  • Historically, Shares Outstanding has averaged $49.5 million across 5 years, with a median of $41.5 million in 2019.
  • Biggest five-year swings in Shares Outstanding: decreased 4.45% in 2017 and later skyrocketed 78.4% in 2021.
  • Tracing NUMD's Shares Outstanding over 5 years: stood at $37.6 million in 2017, then increased by 9.88% to $41.3 million in 2018, then rose by 7.76% to $44.5 million in 2019, then rose by 14.73% to $51.0 million in 2020, then soared by 55.5% to $79.3 million in 2021.
  • Business Quant data shows Shares Outstanding for NUMD at $79.3 million in Q4 2021, $79.3 million in Q3 2021, and $79.3 million in Q2 2021.